GERON CORP
For the period ended Dec 31, 2023. Filed Feb 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 28, 2024
GERN$0.97-2.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity
| Accumulated | ||||||
|---|---|---|---|---|---|---|
| Additional · Other · Total | ||||||
| Common Stock · Paid-In · Accumulated · Comprehensive · Stockholders' | ||||||
| Shares | Amount | Capital | Deficit | Gain (Loss) | Equity | |
| (In thousands, except share data) | ||||||
| Balances at December 31, 2020 | 310,566,853 | $310 | $1,366,188 | $(1,155,629) | $78 | 210,947 |
| Net loss | — | — | — | (116,112) | — | (116,112) |
| Other comprehensive loss | — | — | — | — | (251) | (251) |
| Issuance of common stock in connection with at market offering, net of issuance costs of $470 | 10,571,556 | 11 | 20,374 | — | — | 20,385 |
| Issuance of common stock in connection with exercise of warrants | 1,906,341 | 2 | 2,477 | — | — | 2,479 |
| Stock-based compensation related to issuance of common stock and options in exchange for services | 20,783 | — | 91 | — | — | 91 |
| Issuances of common stock under equity plans | 666,058 | 1 | 796 | — | — | 797 |
| Stock-based compensation for equity- based awards to employees and directors | — | — | 8,080 | — | — | 8,080 |
| Balances at December 31, 2021 | 323,731,591 | 324 | 1,398,006 | (1,271,741) | (173) | 126,416 |
| Net loss | — | — | — | (141,901) | — | (141,901) |
| Other comprehensive loss | — | — | — | — | (68) | (68) |
| Foreign currency translation adjustment | — | — | — | — | 22 | 22 |
| Issuance of common stock, pre-funded warrant and warrants to purchase common stock in public offering, net of issuance costs of $5,066 | 53,333,334 | 53 | 69,863 | — | — | 69,916 |
| Issuance of common stock in connection with exercise of warrants | 11,663,387 | 12 | 15,151 | — | — | 15,163 |
| Stock-based compensation related to issuance of common stock and options in exchange for services | 15,962 | — | 264 | — | — | 264 |
| Issuances of common stock under equity plans | 1,518,250 | 1 | 2,184 | — | — | 2,185 |
| Stock-based compensation for equity- based awards to employees and directors | — | — | 8,001 | — | — | 8,001 |
| Balances at December 31, 2022 | 390,262,524 | 390 | 1,493,469 | (1,413,642) | (219) | 79,998 |
| Net loss | — | — | — | (184,127) | — | (184,127) |
| Other comprehensive loss | — | — | — | — | 431 | 431 |
| Foreign currency translation adjustment | — | — | — | — | (27) | (27) |
| Issuance of common stock, pre-funded warrant and warrants to purchase common stock in public offering, net of issuance costs of $14,507 | 68,007,741 | 68 | 213,269 | — | — | 213,337 |
| Issuance of common stock in connection with exercise of warrants | 77,349,858 | 78 | 105,834 | — | — | 105,912 |
| Stock-based compensation related to issuance of common stock and options in exchange for services | 36,864 | 1 | 828 | — | — | 829 |
| Issuances of common stock under equity plans | 9,255,228 | 8 | 13,062 | — | — | 13,070 |
| Stock-based compensation for equity- based awards to employees and directors | — | — | 18,526 | — | — | 18,526 |
| Balances at December 31, 2023 | 544,912,215 | $545 | $1,844,988 | $(1,597,769) | $185 | $247,949 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.